Anavex is a pharmaceutical company engaged in the development of drug candidates.
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Last: | $4.13 |
---|---|
Change Percent: | 0.24% |
Open: | $4.1 |
Close: | $4.13 |
High: | $4.18 |
Low: | $4.07 |
Volume: | 558,360 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
2024-06-23 11:32:35 ET Summary Acadia Pharmaceuticals, Inc. shares recently hit their lowest level since Daybue approval due to Nuplazid Phase 3 trial failure for schizophrenia. Despite setbacks, Acadia has strong financials with $470.5 million in cash and investments, and is trad...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
Message Board Posts | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Subject | By | Source | When |
---|---|---|---|
Exactly why was that outcome unexpected? If the Rett | Investor2014 | investorshub | 07/02/2024 10:18:13 PM |
It's a holiday week. What did you expect | Steady_T | investorshub | 07/02/2024 10:05:50 PM |
Early on, Merck, Lundbeck and Takeda were willing | powerwalker | investorshub | 07/02/2024 9:36:13 PM |
Let me know when wall street and most | BDR10 | investorshub | 07/02/2024 9:32:35 PM |
X39 lifewave | McMagyar | investorshub | 07/02/2024 9:28:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) shares. Investors, who purchased Anavex Life Sciences Corp. (NASDAQ: AVXL) shares prior to Februa...